Difference between revisions of "Gail K. Naughton"
Jump to navigation
Jump to search
WikiModEn2 (talk | contribs) (Add SEEALSO section.) |
WikiModEn2 (talk | contribs) (Add degrees.) |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
| − | '''Gail K. Naughton''' was president and COO of [[Advanced Tissue Sciences]], which produced a living [[skin]] product call [[Dermagraft]] used to help healing of diabetic foot ulcers. Dermagraft is now being made in San Diego by a subsidiary of [https://www.takeda.com/newsroom/newsreleases/2019/takeda-completes-acquisition-of-shire-becoming-a-global-values-based-rd-driven-biopharmaceutical-leader/ Shire], a medical company based in Dublin, Ireland. | + | '''Gail K. Naughton''', Ph.D., MBA, B.S., was president and COO of [[Advanced Tissue Sciences]], which produced a living [[skin]] product call [[Dermagraft]] used to help healing of diabetic foot ulcers. Dermagraft is now being made in San Diego by a subsidiary of [https://www.takeda.com/newsroom/newsreleases/2019/takeda-completes-acquisition-of-shire-becoming-a-global-values-based-rd-driven-biopharmaceutical-leader/ Shire], a medical company based in Dublin, Ireland. |
Naughton founded [[Histogen]] in 2007, when she was dean of {{UNI|San Diego State University|SDSU}}'s College of Business Administration. Naughton, who had been dean since 2002, left in 2010 to focus on [[Histogen]].<ref>{{REFweb | Naughton founded [[Histogen]] in 2007, when she was dean of {{UNI|San Diego State University|SDSU}}'s College of Business Administration. Naughton, who had been dean since 2002, left in 2010 to focus on [[Histogen]].<ref>{{REFweb | ||
| Line 12: | Line 12: | ||
{{SEEALSO}} | {{SEEALSO}} | ||
* [[United States of America]] | * [[United States of America]] | ||
| + | {{LINKS}} | ||
| + | * {{REFweb | ||
| + | |url=https://www.lji.org/team-member/gail-naughton-ph-d-mba/ | ||
| + | |title=Gail K. Naughton, Ph.D., MBA | ||
| + | |last= | ||
| + | |first= | ||
| + | |init= | ||
| + | |publisher=La Jolla Institute for Imunology | ||
| + | |date= | ||
| + | |accessdate=2024-05-02 | ||
| + | }} | ||
{{REF}} | {{REF}} | ||
Latest revision as of 15:30, 2 May 2024
Gail K. Naughton, Ph.D., MBA, B.S., was president and COO of Advanced Tissue Sciences, which produced a living skin product call Dermagraft used to help healing of diabetic foot ulcers. Dermagraft is now being made in San Diego by a subsidiary of Shire, a medical company based in Dublin, Ireland.
Naughton founded Histogen in 2007, when she was dean of San Diego State University's College of Business Administration. Naughton, who had been dean since 2002, left in 2010 to focus on Histogen.[1]
See also
External links
Gail K. Naughton, Ph.D., MBA
, La Jolla Institute for Imunology. Retrieved 2 May 2024.
References
- ↑ (5 September 2012).
U.S. Patent issued for Histogen's Novel Cell Growth Process
, Histogen. Retrieved 16 November 2012.